Esther Marco

发表

Molecular determinants of topoisomerase I poisoning by lamellarins: comparison with camptothecin and structure-activity relationships.

C. Bailly, F. Gago, E. Marco, 2005, Journal of medicinal chemistry.

Antitumor activity, X-ray crystal structure, and DNA binding properties of thiocoraline A, a natural bisintercalating thiodepsipeptide.

C. Bailly, J. Vaquero, F. Gago, 2007, Journal of medicinal chemistry.

Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin.

S. Moreno, F. Gago, E. Marco, 2006, Cancer research.

Stepwise dissection and visualization of the catalytic mechanism of haloalkane dehalogenase LinB using molecular dynamics simulations and computer graphics.

F. Gago, J. Damborský, E. Marco, 2007, Journal of molecular graphics & modelling.

A 3.(ET743)-DNA complex that both resembles an RNA-DNA hybrid and mimicks zinc finger-induced DNA structural distortions.

J. Mendieta, F. Gago, E. Marco, 2002, Journal of medicinal chemistry.

Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin

J. Vaquero, F. Gago, E. Marco, 2008, Molecular Cancer Therapeutics.

Mechanism of Activation of a G Protein-coupled Receptor, the Human Cholecystokinin-2 Receptor*

E. Marco, I. Tikhonova, C. Escrieut, 2007, Journal of Biological Chemistry.

Overcoming the Inadequacies or Limitations of Experimental Structures as Drug Targets by Using Computational Modeling Tools and Molecular Dynamics Simulations

Federico Gago, F. Gago, E. Marco, 2007, ChemMedChem.

Protein–protein interactions at an enzyme–substrate interface: Characterization of transient reaction intermediates throughout a full catalytic cycle of Escherichia coli thioredoxin reductase

F. Gago, David Rodriguez-Larrea, J. M. Sanchez-Ruiz, 2010, Proteins.

Role of stacking interactions in the binding sequence preferences of DNA bis-intercalators: insight from thermodynamic integration free energy simulations

F. J. Luque, F. Gago, E. Marco, 2005, Nucleic acids research.

New anthranilic acid based antagonists with high affinity and selectivity for the human cholecystokinin receptor 1 (hCCK1-R).

F. Gasparrini, A. Ciogli, E. Marco, 2011, Journal of medicinal chemistry.

Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin

B. Maigret, E. Marco, I. Tikhonova, 2008, Regulatory Peptides.

Assessment by molecular dynamics simulations of the structural determinants of DNA-binding specificity for transcription factor Sp1.

Federico Gago, Raquel García-Nieto, F. Gago, 2003, Journal of molecular biology.

Linking Non-peptide Ligand Binding Mode to Activity at the Human Cholecystokinin-2 Receptor*

C. Escrieut, D. Fourmy, C. Low, 2008, Journal of Biological Chemistry.